Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 21, 1993
Grant Date -
N/A
app pub date -
May 19, 1992
filing date -
May 19, 1992
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully